Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 3 pseudogene 1 (CCT3P1) is a **pseudogene** corresponding to the canonical CCT3 gene, which encodes a subunit of the cytosolic chaperonin containing TCP1 (CCT) complex, also called TRiC. CCT3P1 is located in the human genome but contains disabling mutations such as frame-shifts or premature stop codons and does not produce a functional protein. As such, unlike the protein-coding CCT3 gene—important for actin and tubulin folding and implicated in various cellular processes and diseases—CCT3P1 does not have a known biological or pathological function and is not pursued as a therapeutic target[1][6].
None (not a protein or active RNA product)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 3 pseudogene 1 (CCT3P1).